BioSpace News Archive

Drug Development

Alligator Bioscience to Present the ATOR-1015 Phase I Study Outline at ASCO

Alligator Bioscience today announces that the outline of the ongoing Phase I study with the bispecific drug candidate ATOR-1015 will be showcased at the American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago on May 31- June 4, 2019.

May 16, 2019
·
3 min read
Deals

Thermo Fisher Scientific to Acquire Manufacturing Site in Cork, Ireland, from GSK

Expands global footprint for complex API manufacturing

May 16, 2019
·
2 min read
Biotech Bay

FARAPULSE featured prominently at 2019 HRS Scientific Sessions

Late Breaking Clinical Trial Presentation and concurrent JACC publication highlight FARAPULSE technology’s potential to achieve new standard of care in treating Atrial Fibrillation

May 16, 2019
·
4 min read
AMRA Medical Announces Its Technology Has the Ability to Predict the Occurrence of Coronary Heart Disease and Type 2 Diabetes

AMRA Medical and UK Biobank data provides evidence to predict the occurrence of disease

May 16, 2019
·
3 min read
Beth Stavola to Present at Canadian Cannabis Capital Markets Conference in London

Ms. Stavola recently named #1 on the “2019 Cannabis Business Executive Power Women in Cannabis” list.

May 16, 2019
·
2 min read
Genetown

Updated Libtayo® (cemiplimab-rwlc) Results Reinforce Durable and Substantial Response Rates in Advanced Cutaneous Squamous Cell Carcinoma

New data at ASCO include more than double the patients previously reported; median overall survival still not reached with a median follow-up of up to 17 months

May 16, 2019
·
19 min read
Biotech Bay

ALX Oncology to Present ALX148 Clinical Data at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

ALX Oncology announced that ALX148 clinical results have been selected for presentation in the Poster Discussion Session at the 2019 ASCO Annual Meeting, May 31 – June 4, 2019 at the McCormick Place Convention Center in Chicago, Illinois.

May 16, 2019
·
1 min read
Deals

Verastem Oncology to Present at the 20th Annual B. Riley FBR Institutional Investor Conference

Verastem, Inc. announced that the Company will present at the 20th Annual B. Riley FBR Institutional Investor Conference on Thursday, May 23, 2019 at 1:30 p.m. PDT in Beverly Hills, CA.

May 16, 2019
·
1 min read
Business

BVI Medical names Shervin Korangy as President and Chief Executive Officer

BVI Medical, Inc., a leading developer, manufacturer, and marketer of surgical devices for the ophthalmic marketplace, announced that it has named Shervin Korangy as President and Chief Executive Officer.

May 16, 2019
·
3 min read
Pharm Country

Five nonprofit organizations to receive up to $250,000 through Novartis STEP Program™ to support sickle cell patient initiatives

Novartis announced that five nonprofit organizations will receive a total of nearly $250,000 in funding through the company’s STEP (Solutions to Empower Patients) Program™.

May 16, 2019
·
4 min read